PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of bmcpediBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Pediatrics
 
From:
Published online 2012 April 4. doi: 10.1186/1471-2431-12-43

Table 5

Incidence of adverse events and short-term neonatal outcomes

Variable*BP-NCPAP
(N = 67)
NCPAP
(N = 69)
P value
Adverse events

Nasal septum breakdown [N (%)]6 (8.9%)9 (13%)0.59

Eyelid edema [N (%)]3 (4.5%)2 (2.8%)0.68

Feeding intolerance [N (%)]8 (11.9%)17 (25%)0.08

Abdominal distension [N (%)]16 (23.8%)8 (12%)0.07

Pneumothorax [N (%)]00

Short-term neonatal outcomes

Mortality [N (%)]3 (4%)5 (7%)0.49

New-onset sepsis after extubation [N (%)]8 (12%)5 (7%)0.35

Bronchopulmonary dysplasia (oxygen dependency at 36 weeks PMA) [N (%)]21 (31.3%)22 (31.8%)1.0

Necrotising enterocolitis [N (%)]7 (10.4%)7 (10.1%)0.95

Grade 3/4 IVH/PVL1/62 (1.6%)5/65(7.7%)0.41

ROP > stage 2 [N (%)]11 (17%)3 (5%)0.02

Patent ductus arteriosus [N (%)]36 (53.7%)35 (51%)0.82

*IVH = Intraventricular hemorrhage, N = Number, % = Percent, PVL = Periventricular leucomalacia, ROP = Retinopathy of prematurity